摘要
目的:比较不同他汀类治疗老年冠心病伴高胆固醇血症的疗效。方法:选择2016年11月—2019年11月在河南省人民医院治疗的360例老年冠心病伴高胆固醇血症患者,随机分为A、B、C三组进行不同他汀类治疗,向A组(n=120)提供普伐他汀,B组(n=120)提供瑞舒伐他汀,C组(n=120)提供阿托伐他汀,比较三组不同他汀类治疗后的效果。结果:在血脂水平比较上,三组在治疗后的各项血脂指标上均表现好于治疗前;B组总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)上的表现较A、C两组更好,差异具有统计学意义,P<0.05。结论:不同他汀类药物在治疗老年冠心病上都能够取得较好疗效,安全性有保障,但相对来说,瑞舒伐他汀的疗效更佳,在临床应用更广。
Objective:To compare the therapeutic effect of different statins on senile coronary heart disease with hypercholesterolemia.Method:360 elderly patients with coronary heart disease and hypercholesterolemia who were treated in Henan people’s Hospital from November 2016 to November 2019 were randomly divided into three groups:A,B and C for different statins.Pravastatin was provided to group A(n=120),rosuvastatin was provided to group B(n=120),and atorvastatin was provided to group C(n=120).The effects of different statins in three groups were compared.Result:In the comparison of blood lipid level,all the blood lipid indexes of three groups after treatment were better than before treatment;the total cholesterol(TC)and low-density lipoprotein cholesterol(LDL-C)of group B were better than those of group A and C,the difference was statistically significant(P<0.05).Conclusion:Different statins can achieve better efficacy and safety in the treatment of elderly coronary heart disease,but relatively speaking,rosuvastatin has better efficacy and wider clinical application.
作者
钱鹏
王心慧
曹选超
徐先静
黄改荣
段明勤
Qian Peng(Department of Geriatrics,Henan people’s Hospital,Zhengzhou Henan 450003)
出处
《黑龙江医药》
CAS
2021年第1期9-12,共4页
Heilongjiang Medicine journal
基金
河南省医学科技攻关计划普通项目(编号:201602226)。
关键词
老年冠心病
伴高胆固醇血症
他汀类
Elderly coronary heart disease
Hypercholesterolemia
Statins